Houston, United States
Research view
Colorectal cancer: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.
- All targets
- TP53 6
- KRAS 57
- PD-1 108
- BRAF 36
- EGFR 32
- PD-L1 26
- PI3K 2
- STAT3 0
- CTNNB1 1
- AKT 0
- RAS 31
- HER2 38
- mTOR 1
- MAPK 1
- VEGF 14
- ERK 0
- STING 0
- NRF2 0
- PPAR 0
- CTLA-4 16
- HIF-1 0
- COX-2 5
- JNK 0
- AMPK 0
- MYC 0
- PTEN 1
- YAP 0
- GPX4 0
- NRAS 8
- IL-6 0
- JAK 0
- MET 7
- PARP 1
- CXCR4 0
- TNF 0
- NLRP3 0
- BCL-2 0
- HSP90 0
- PIK3CA 2
- GLP-1 1
- HDAC 2
- METTL3 0
- MEK 1
- CDK4/6 2
- CD47 1
- BRCA1 1
- FGFR 0
- NTRK 1
- B7-H3 5
- EZH2 0
- FAK 1
- HMGB1 0
- TROP2 4
- MUC1 2
- ATM 2
- IDO1 1
- IL-1 0
- PCSK9 3
- PINK1 0
- SHP2 0
EU-13 is a filter, not a ranking: it only narrows the list.
Rochester, United States
New York, United States
Duarte, United States
Guangzhou, China
Guangzhou, China
Chengdu, China
Massachusetts General Hospital · Boston, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Cancer Immunol Res, Jan 2026T-cell Subset Features and Distributions Evolve across the Colorectal Precancer-Cancer Spectrum.
Shanghai, China
Beijing, China
National Cancer Center Hospital East · Kashiwa, Japan
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Eur J Surg Oncol, Nov 2025Response to chemotherapy as a key factor in time to surgical failure following conversion hepatectomy for initially unresectable colorectal liver metastases: A retrospective cohort study.
State Key Laboratory of Oncology in South China · Guangzhou, China
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Signal Transduct Target Ther, Dec 2025YTHDF1 targets the chemotherapy response by suppressing NOTCH1-induced stemness in colorectal cancer.
Boston, United States
Washington University in St. Louis · St Louis, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Cancer Res, Mar 2026Integration of Short- and Long-Read RNA Sequencing Enables the Discovery of Circular RNAs.
Chinese University of Hong Kong · Hong Kong, Hong Kong
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Signal Transduct Target Ther, Dec 2025YTHDF1 targets the chemotherapy response by suppressing NOTCH1-induced stemness in colorectal cancer.
San Francisco, United States
Brigham and Women's Hospital · Boston, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Cancer Epidemiol Biomarkers Prev, Mar 2026Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer.
Milan, Italy
Rozzano, Italy
Shanghai, China
Stanford, United States
University Medical Center Utrecht · Utrecht, Netherlands
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Ann Surg Oncol, Mar 2026ASO Visual Abstract: Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.
Beijing, China
Hangzhou, China
24 of 46+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Who stopped a trial, and why
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Terminated
“The study was closed due to accrual.”Registry text, quoted unchanged. Source
Terminated
PF-07284892 in Participants With Advanced Solid Tumors
“The study was prematurely discontinued due to strategic reasons. The PF-07284892 program will continue”Registry text, quoted unchanged. Source
Terminated
ZN-c3 in Adult Participants With Metastatic Colorectal Cancer
“Study terminated due to change in therapeutic landscape.”Registry text, quoted unchanged. Source
Terminated
“Funding terminated due to business reasons”Registry text, quoted unchanged. Source
Terminated
Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer
“DSMC-directed closure”Registry text, quoted unchanged. Source
Terminated
Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors
“Not related to safety concerns or lack of efficacy”Registry text, quoted unchanged. Source
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 133
- Organoids 108
- Mendelian Randomization Analysis 49
- CRISPR-Cas Systems 34
- Gene Expression Profiling 337
- Sequence Analysis, RNA 29
- Whole Genome Sequencing 22
- Exome Sequencing 26
- Proteomics 107
- Metabolomics 92
- Mass Spectrometry 42
- Flow Cytometry 113
- Immunohistochemistry 208
- Liquid Biopsy 36
- Circulating Tumor DNA 119
- Xenograft Model Antitumor Assays 432
- Positron-Emission Tomography 38
- Magnetic Resonance Imaging 196
- Machine Learning 210
- Deep Learning 142
- Cohort Studies 316
- Genome-Wide Association Study 65
A Multimodal Framework to Assess Patient-Derived Colon Tumor Organoid-Immune Cell Co-cultures.
Perforin and Granulysin-Mediated Cytotoxicity in Colorectal Cancer Patients.
Characterization of Lymphocyte Subsets in Peripheral Blood of Patients with Colorectal Cancer.
Single-cell mass cytometry reveals distinct immune signatures in colorectal cancer.
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed. Machine-matched links are labelled.